Skip to main content
. 2016 Apr 20;7(29):45094–45111. doi: 10.18632/oncotarget.8862

Figure 3. Comparison between QUS parameters A-G. and the RECIST-based tumor size reduction H. for tracking patient tumors during chemotherapy.

Figure 3

QUS and RECIST values were averaged over responder (blue diamond) and non-responder (red square) groups, and plotted over the treatment time. Patients were grouped based on their pathological clinical response determined post-chemotherapy. All values were normalized to week 0 by subtraction. Error bars represent standard error of the mean.